Strategic Advice and Regulatory Analysis
BlueReg experienced consultants can provide insight into all regulatory requirements for France:
- Drug Registration
- Early Access Programmes
- Post Marketing Authorisation Application (MAA) activities
- Promotional material review
- Quality systems and audits
- Interactions with healthcare professionals includingcompliance with the French laws (DMOS, Transparence de liens, Charte de l’information promotionnelle)
- Pricing and reimbursement
Corinne Schmitz – Women for Future – Pharmaceutical Industry Expert
This week, “La Tribune” and its partner Bpifrance have decided to present Corinne Schmitz, CEO...
The French system for preventing and managing shortages
The French regulation on the prevention and management of stock shortages of medicinal products is...